UnknownPHASE1, PHASE2NCT02579044
Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria
Studying Hutchinson-Gilford progeria syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Boston Children's Hospital
- Principal Investigator
- Monica Kleinman, M.D.Boston Children's Hospital
- Intervention
- Everolimus and lonafarnib(drug)
- Enrollment
- 80 target
- Eligibility
- 25 years · All sexes
- Timeline
- 2015 – 2023
Study locations (1)
- Boston Children's Hospital, Boston, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02579044 on ClinicalTrials.govOther trials for Hutchinson-Gilford progeria syndrome
Additional recruiting or active studies for the same condition.